Potential areas for collaboration:
• Genotype–phenotype correlation in rare POLA1variants
• Mechanisms of interferon dysregulation
• NK cell biology in XLPDR
• Natural history and longitudinal outcomes
• Therapeutic targeting of interferon pathways
POLA1 XLPDR